The relationship between socio-economic status and diagnosed Type 2 diabetes is changing with economic growth in Nanjing, China
Xu F, He J, Wang Z, et al.
Diabetic Med. Pub. online February 8, 2018
Leggi
Breaking news
Planned birth at or near term for improving health outcomes for pregnant women with pre-existing diabetes and their infants
Biesty LM, Egan AM, Dunne F, et al.
The Cochrane Library. Pub. online 9 February 2018
Leggi
Weight Loss, Diabetes, and Beyond
Pareek M, Schauer PR, Kaplan LM, et al.
J Am Coll Cardiol 2018;71(6)
Leggi
Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
Patorno E, Goldfine AB, Schneeweiss S, et al.
BMJ 2018;360:k119
Leggi
Cancer risk associated with chronic diseases and disease markers: prospective cohort study
Tu H, Wen CP, Tsai SP, et al.
BMJ 2018;360:k134
Leggi
Hypertension and Diabetes Mellitus: Coprediction and Time Trajectories
Tsimihodimos V, Gonzalez-Villalpando C, Meigs JB, et al.
Hypertension 2018;71:422-8
Leggi
Empagliflozin across the stages of diabetic heart disease (Editorial)
Paneni F
Eur Heart J 2018; 39 (5): 371-3
Leggi
Diabetes Mellitus and Right Ventricular Dysfunction in Heart Failure With Preserved Ejection Fraction
Thomas M. Gorter, Koen W. Streng, et al.
Am J Cardiol 2018;121:(5):621-7
Leggi
Age at Menarche and Incidence of Diabetes: A Prospective Study of 300,000 Women in China
Yang L, Li L, Peters SAE, et al.
Am J Epidemiol 2018;187(2):190-8
Leggi
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME trial
Fitchett D, Butler J, van de Borne P, et al.
Eur Heart J 2018;39(5):363-70
Leggi